153 related articles for article (PubMed ID: 36840474)
1. Nucleos(t)ide analogues altered quasispecies composition of hepatitis B virus (HBV)-resistant mutations in serum HBV DNA and serum HBV RNA.
Liao H; Zhang H; Shao J; Li X; Zheng WV; Li L; Yu G; Si L; Zhou T; Yao Z; Dai J; Xu D; Cheng G; Qu J; Liu Y; Chen J; Lu F
J Med Virol; 2023 Mar; 95(3):e28612. PubMed ID: 36840474
[TBL] [Abstract][Full Text] [Related]
2. Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients.
Cheng HR; Yang HC; Lin SR; Yang TY; Lin YY; Su TH; Tseng TC; Liu CJ; Kao JH
Hepatol Int; 2021 Jun; 15(3):582-592. PubMed ID: 33886088
[TBL] [Abstract][Full Text] [Related]
3. Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients.
Wang Y; Liu Y; Liao H; Deng Z; Bian D; Ren Y; Yu G; Jiang Y; Bai L; Liu S; Liu M; Zhou L; Chen Y; Chen X; Duan Z; Lu F; Zheng S
Int J Med Sci; 2022; 19(5):858-866. PubMed ID: 35693741
[No Abstract] [Full Text] [Related]
4. The association of the heterogeneity of HBV reverse transcriptase quasispecies with antiviral efficacy after treatment with nucleos(t)ide analogues for 10 years.
Zhou TC; Liu FW; Fan JH; Zhang SH; Lv SQ; Yu ZY; Zhang YM; Zhang L; Wei J
Infect Genet Evol; 2021 Apr; 89():104706. PubMed ID: 33418145
[TBL] [Abstract][Full Text] [Related]
5. Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B.
Lei J; Wang Y; Wang LL; Zhang SJ; Chen W; Bai ZG; Xu LY
Virol J; 2013 Oct; 10():313. PubMed ID: 24160943
[TBL] [Abstract][Full Text] [Related]
6. Increased intrahepatic quasispecies heterogeneity correlates with off-treatment sustained response to nucleos(t)ide analogues in e antigen-positive chronic hepatitis B patients.
Chen L; Gan QR; Zhang DQ; Yao LF; Lin RS; Li Q; Lin MH; Yu DM; Zhang XX; Pan C
Clin Microbiol Infect; 2016 Feb; 22(2):201-207. PubMed ID: 26493847
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Serum Hepatitis B Virus RNA Levels and Quasispecies Evolution Patterns between Entecavir and Pegylated-Interferon Mono-treatment in Chronic Hepatitis B Patients.
Yu XQ; Wang MJ; Yu DM; Chen PZ; Zhu MY; Huang W; Han Y; Gong QM; Zhang XX
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32554476
[TBL] [Abstract][Full Text] [Related]
8. Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.
Mirandola S; Campagnolo D; Bortoletto G; Franceschini L; Marcolongo M; Alberti A
J Viral Hepat; 2011 Jul; 18(7):e212-6. PubMed ID: 21692935
[TBL] [Abstract][Full Text] [Related]
9. Early changes in quasispecies variant after antiviral therapy for chronic hepatitis B.
Liang Y; Yano Y; Putri WA; Mardian Y; Okada R; Tanahashi T; Murakami Y; Hayashi Y
Mol Med Rep; 2018 Apr; 17(4):5528-5537. PubMed ID: 29393485
[TBL] [Abstract][Full Text] [Related]
10. Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy.
Liu S; Deng R; Zhou B; Liang X; Liu Z; Peng J; Chen J; Zhou Y; Guo Y; Chen Y; Li W; Shen S; Lu X; Zhao S; Liao X; Liang H; Lan Y; Hou J; Fan R; Sun J
J Infect Dis; 2022 Sep; 226(5):881-890. PubMed ID: 34931674
[TBL] [Abstract][Full Text] [Related]
11. Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues.
Wang Y; Liao H; Deng Z; Liu Y; Bian D; Ren Y; Yu G; Jiang Y; Bai L; Liu S; Liu M; Zhou L; Chen Y; Duan Z; Lu F; Zheng S
J Viral Hepat; 2022 Jun; 29(6):420-431. PubMed ID: 35274400
[TBL] [Abstract][Full Text] [Related]
12. [Demographic characteristics and associated influencing factors in treated patients with chronic hepatitis B with hypoviremia : a single-center retrospective cross-sectional study].
Li T; Kong Y; Liu YY; Liu TF; Ma AD; Li LQ; Pei ZY; Zhang LY
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):42-48. PubMed ID: 36948848
[No Abstract] [Full Text] [Related]
13. [The potential use of serum HBV RNA to guide the functional cure of chronic hepatitis B].
Lu FM; Wang J; Chen XM; Jiang JN; Zhang WH; Zhao JM; Ren H; Hou JL; Xia NS
Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):105-110. PubMed ID: 28297795
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China.
Zhao Y; Wu J; Sun L; Liu G; Li B; Zheng Y; Li X; Tao J
Braz J Infect Dis; 2016; 20(2):173-8. PubMed ID: 26876337
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues.
Jansen L; Kootstra NA; van Dort KA; Takkenberg RB; Reesink HW; Zaaijer HL
J Infect Dis; 2016 Jan; 213(2):224-32. PubMed ID: 26216905
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients.
Kim HJ; Cho JY; Kim YJ; Gwak GY; Paik YH; Choi MS; Koh KC; Paik SW; Yoo BC; Lee JH
Korean J Intern Med; 2015 Jan; 30(1):32-41. PubMed ID: 25589833
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Nucleos(t)ide Analogues Discontinuation Relapse: Hepatitis B Virus RNA versus Hepatitis B Surface Antigen.
Wu S; Li T; Liu F; Yin D; Zhang L; Wang L
J Coll Physicians Surg Pak; 2024 May; 34(5):545-550. PubMed ID: 38720214
[TBL] [Abstract][Full Text] [Related]
18. Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients.
Ono A; Suzuki F; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Saitou S; Arase Y; Ikeda K; Kobayashi M; Watahiki S; Mineta R; Kumada H
J Hepatol; 2012 Sep; 57(3):508-14. PubMed ID: 22659518
[TBL] [Abstract][Full Text] [Related]
19. Amino acid polymorphism in the reverse transcriptase region of hepatitis B virus and the relationship with nucleos(t)ide analogues treatment for preventing mother-to-infant transmission.
Chen J; Yan L; Zhu FC; Liu JX; Li RC; Wang FZ; Li J; Zhuang H
J Med Virol; 2014 Aug; 86(8):1288-95. PubMed ID: 24777553
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional evaluation of circulating hepatitis B virus RNA and DNA: Different quasispecies?
Garcia-Garcia S; Cortese MF; Tabernero D; Gregori J; Vila M; Pacín B; Quer J; Casillas R; Castillo-Ribelles L; Ferrer-Costa R; Rando-Segura A; Trejo-Zahínos J; Pumarola T; Casis E; Esteban R; Riveiro-Barciela M; Buti M; Rodríguez-Frías F
World J Gastroenterol; 2021 Nov; 27(41):7144-7158. PubMed ID: 34887634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
